Opportunity Information: Apply for PAR 13 353
Apply for PAR 13 353
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Revision Requests for Active Alzheimers Disease Centers (P50)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866 Aging Research.
- This funding opportunity was created on Sep 16, 2013 and posted on Sep 16, 2013.
- Applicants must submit their applications by Jan 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Faith based or Community based Organizations Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, PAR-13-353, is a National Institutes of Health (NIH) announcement from the National Institute on Aging (NIA) that specifically supports revision requests to already-funded NIA Alzheimers Disease Centers (ADCs) operating under the P50 center grant mechanism. The purpose is not to create new ADCs or start a brand-new center program, but to let existing, active NIA-supported ADCs broaden or enhance what they are already doing. In NIH terms, these revision applications were previously referred to as "competing supplements," and the key idea is expansion of scope for an ongoing parent award rather than a separate, stand-alone project.
The revisions can take several forms, as long as they meaningfully add to or improve the current center. Applicants may propose adding an entirely new core, adding a new research project, or making substantial changes to an existing core. In practice, this means an ADC could request support to build new shared infrastructure, add a specialized scientific or clinical capability, or introduce a new research line that complements and strengthens the overall center mission. The announcement is centered on the P50 structure, which typically includes multiple coordinated projects and shared cores that provide services, resources, and coordination across the center. The revision mechanism is meant to help centers adapt and grow in a targeted way while maintaining integration with the existing ADC.
A major constraint of the opportunity is timing and period of support. The revision request cannot extend beyond the end date of the parent P50 award. In other words, even if the revision proposes new activities, the funding being requested must fit within the remaining project period of the existing ADC grant. This keeps the revision tied to the life of the current award and prevents applicants from using a revision to effectively prolong the center beyond its approved end date.
From an administrative and classification standpoint, the opportunity is a discretionary grant in the health activity category, listed under CFDA 93.866 (Aging Research). There is no cost sharing or matching requirement, so applicants are not required to contribute a specified portion of funds as a condition of receiving the award. The opportunity was posted and created on September 16, 2013, with an original and current closing date of January 7, 2017, and an archive date of February 7, 2017, meaning it is no longer active for new submissions under that specific announcement.
Eligibility is limited and tied to the existence of an active NIA-supported Alzheimers Disease Center P50. The announcement notes that additional categories of eligible applicants may include faith-based or community-based organizations, but foreign participation is explicitly restricted. Non-U.S. (foreign) institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed. These limitations make the opportunity essentially domestic in scope and designed to support U.S.-based ADC infrastructure and research expansion.
For applicants and administrators looking for the official program details, requirements, and any instructions that were in effect during the open period, NIH provided an additional information link to the full announcement on the NIH grants site (grants.nih.gov). The contact information included in the listing is geared toward technical issues accessing the announcement online, directing users to the NIH Office of Extramural Research (OER) webmaster email for assistance with access or linking problems.
Frequently Asked Questions (FAQs): NIH/NIA Grant Opportunity PAR-13-353 (Revisions to NIA Alzheimer's Disease Centers)
1) What is PAR-13-353?
PAR-13-353 is a National Institutes of Health (NIH) funding announcement from the National Institute on Aging (NIA) that supports revision requests to already-funded NIA Alzheimer's Disease Centers (ADCs) that operate under the P50 center grant mechanism.
2) Is this opportunity meant to create a new Alzheimer's Disease Center (ADC)?
No. The purpose is not to create new ADCs or start a brand-new center program. It is specifically intended to let existing, active NIA-supported ADCs broaden or enhance their current, ongoing center activities.
3) What kind of application is this (in NIH terms)?
This is a revision application to an ongoing parent award. The announcement notes that these revision applications were previously referred to as "competing supplements." The key concept is an expansion of scope for the existing funded center, rather than a separate, stand-alone project.
4) What grant mechanism does this announcement apply to?
It applies to NIA Alzheimer's Disease Centers that are funded through the P50 center grant mechanism.
5) Who can apply?
Eligibility is limited to organizations that already have an active, NIA-supported Alzheimer's Disease Center (ADC) P50 award. The announcement also notes that additional categories of eligible applicants may include faith-based or community-based organizations, but eligibility is still tied to the existence of an active NIA-supported ADC P50.
6) Can a foreign (non-U.S.) institution apply?
No. Foreign participation is explicitly restricted. Non-U.S. (foreign) institutions are not eligible to apply under this opportunity.
7) Can a U.S. organization apply if the work will be done by a non-U.S. component?
No. Non-U.S. components of U.S. organizations are not eligible under this opportunity.
8) Are foreign components (as defined by NIH) allowed?
No. Foreign components (as defined in the NIH Grants Policy Statement) are not allowed under this announcement.
9) What types of revisions are allowed?
The revisions can take several forms as long as they meaningfully add to or improve the current center. Examples described in the announcement include:
- Adding an entirely new core
- Adding a new research project
- Making substantial changes to an existing core
10) What does "expansion of scope" mean here?
It means the center is requesting support to broaden or enhance what it is already doing under its existing, active P50 ADC award. The intent is to add capabilities or activities that complement and strengthen the overall center mission while staying integrated with the existing ADC structure.
11) Can the revision request be used to extend the ADC beyond the parent award end date?
No. A major constraint is timing and period of support. The revision request cannot extend beyond the end date of the parent P50 award.
12) How long can the revision be supported?
Any funding requested through the revision must fit within the remaining project period of the existing (parent) ADC P50 grant and cannot go past that parent award end date.
13) Is the revision considered a separate, stand-alone project?
No. The revision is tied to the ongoing parent award and is meant to expand or enhance that existing center award, not to function as a separate, independent project.
14) What kinds of center enhancements does the announcement describe as practical examples?
The announcement describes enhancements such as building new shared infrastructure, adding a specialized scientific or clinical capability, or introducing a new research line that complements and strengthens the overall center mission.
15) Why does the announcement emphasize the P50 structure?
The P50 structure typically includes multiple coordinated projects and shared cores that provide services, resources, and coordination across the center. The revision mechanism is intended to help centers adapt and grow in a targeted way while maintaining integration with the existing ADC.
16) What type of grant is this classified as?
From an administrative standpoint, it is listed as a discretionary grant in the health activity category.
17) What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.866, Aging Research.
18) Is cost sharing or matching required?
No. There is no cost sharing or matching requirement stated for this opportunity.
19) When was this opportunity posted?
The opportunity was posted and created on September 16, 2013.
20) What was the closing date for submissions under this announcement?
The original and current closing date listed for this announcement was January 7, 2017.
21) Is PAR-13-353 still open for new applications?
No. The listing includes an archive date of February 7, 2017, which indicates it is no longer active for new submissions under that specific announcement.
22) Where can applicants find the full official announcement details?
NIH provided an additional information link to the full announcement on the NIH grants site (grants.nih.gov). That is the source for the official program details, requirements, and instructions that applied during the open period.
23) Who should be contacted for technical problems accessing the announcement online?
The contact information included is for technical issues accessing the announcement online, directing users to the NIH Office of Extramural Research (OER) webmaster email for assistance with access or linking problems.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: FY 2014 National Environmental Information Exchange Network Grant Program
Previous opportunity: National Park Service Resource Managment Internship Program with GMU
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 353
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 353) also looked into and applied for these:
| Funding Opportunity |
|---|
| Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA (U01) Apply for RFA RM 13 014 Funding Number: RFA RM 13 014 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Advancing the Science of Geriatric Palliative Care (R01) Apply for PA 13 354 Funding Number: PA 13 354 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing the Science of Geriatric Palliative Care (R21) Apply for PA 13 355 Funding Number: PA 13 355 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Advancing the Science of Geriatric Palliative Care (R03) Apply for PA 13 356 Funding Number: PA 13 356 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Centers Without Walls for Collaborative Research in the Epilepsies Sudden Unexpected Death in Epilepsy (SUDEP) (U01) Apply for RFA NS 14 004 Funding Number: RFA NS 14 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Disaster Mental Health Intervention Research Center (P60) Apply for RFA MH 14 090 Funding Number: RFA MH 14 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ryan White Part B HIV Care Grant Program Apply for HRSA 14 047 Funding Number: HRSA 14 047 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Center for Evaluation and Coordination of Training and Research (CECTR) in Tobacco Regulatory Science (U54) Apply for RFA OD 13 117 Funding Number: RFA OD 13 117 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| COOPERATIVE AGREEMENT WITH THE PAN AMERICAN HEALTH ORGANIZATION (PAHO) Protecting the Advances in Polio, Rubella and Measles Elimination Strengthening Immunization Programs in the Americas Apply for CDC RFA GH14 1401 Funding Number: CDC RFA GH14 1401 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Neurological Sciences Academic Development Award (K12) Apply for PAR 13 362 Funding Number: PAR 13 362 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nutrition and Alcohol Related Health Outcomes (R01) Apply for PA 13 359 Funding Number: PA 13 359 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nutrition and Alcohol Related Health Outcomes (R03) Apply for PA 13 360 Funding Number: PA 13 360 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nutrition and Alcohol Related Health Outcomes (R21) Apply for PA 13 361 Funding Number: PA 13 361 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Rural Health Network Development (RHND) Grant Program Apply for HRSA 14 044 Funding Number: HRSA 14 044 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| NEI Translational Research Program (TRP) on therapy for Visual Disorders (R24) Apply for PAR 13 370 Funding Number: PAR 13 370 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| Patient Centered Outcomes Research (PCOR) for Treatment Options in Uterine Fibroids Developing a Prospective Multi Center Practice based Clinical Registry (P50) Apply for RFA HS 14 006 Funding Number: RFA HS 14 006 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $4,000,000 |
| Local Capacity Initiative Apply for RFI 486 14 00001 Funding Number: RFI 486 14 00001 Agency: Thailand USAID Bangkok Category: Health Funding Amount: Case Dependent |
| Health Communication Project Apply for RFA 391 14 000001 Funding Number: RFA 391 14 000001 Agency: Pakistan USAID Islamabad Category: Health Funding Amount: $24,500,000 |
| AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) Apply for HRSA 14 049 Funding Number: HRSA 14 049 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| MEASURE Evaluation Phase IV Apply for SOL OAA 14 000005 Funding Number: SOL OAA 14 000005 Agency: Agency for International Development Category: Health Funding Amount: $181,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 353", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.